Biocom California
Christophe Schilling is an accomplished professional in the biotechnology sector, currently serving as Chief Executive Officer at Geno since January 2000. In addition to this role, Christophe Schilling has held a position on the Board of Directors for BIOCOM since February 2010 and previously served on the Board of Directors for GT Life Sciences from July 2007 to April 2011. Educational qualifications include a PhD in Bioengineering from UC San Diego and a B.S.E. in Biomedical Engineering from Duke University.
This person is not in any teams
Biocom California
Biocom is a business advocate for life sciences companies in California. It represents more than 750 biotechnology, pharmaceutical, digital health, and medical device or diagnostic companies. The company focuses on accelerating the innovation ecosystem and introducing inventive purchasing programs that advance day-to-day business activities.Biocom provides a public voice to the companies and organizations that support local economies and produce novel solutions to improve the human condition. The company’s membership benefits apply to biotechnology, pharmaceutical, medical device, genomics, and diagnostics companies of all sizes as well as to research universities and institutes, CROs, investors, and service providers.Biocom’s main offices are located in San Diego and Los Angeles, with satellite offices in Washington, D.C. and Tokyo.